Dr. Kelly Discusses the Treatment of Patients With ALK+ NSCLC

preview_player
Показать описание
Ronan J. Kelly, MD, MBA, chief of oncology for the ten Baylor Scott and White Health System’s North Texas Cancer Centers and director of oncology at the Baylor Charles A. Sammons Cancer Center at Baylor University Medical Center, discusses the treatment of patients with ALK-positive non–small cell lung cancer.
Рекомендации по теме